Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ASCB A SPAC II Acquisition (ASCB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisHeadlinesOwnershipTrends About A SPAC II Acquisition Stock (NASDAQ:ASCB) 30 days 90 days 365 days Advanced Chart Remove Ads Get A SPAC II Acquisition alerts:Sign Up Key Stats Today's Range N/A50-Day Range$10.96▼$11.4752-Week Range N/AVolume2,300 shsAverage Volume13,818 shsMarket Capitalization$81.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewA SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech primarily in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corp. is a subsidiary of A SPAC II (Holdings) Corp.Read More… Remove Ads Receive ASCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for A SPAC II Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address ASCB Stock News HeadlinesCantor-Affiliated SPAC Files To Go PublicMarch 10 at 7:43 PM | marketwatch.comBridgeBio Oncology to Go Public in SPAC Deal Bringing $450 Million-Plus for Trio of Cancer DrugsMarch 3, 2025 | msn.comLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the policies Trump will put in place. Ten investments with the potential to return 10x or more… but only if you act right now.March 12, 2025 | Porter & Company (Ad)Special Purpose Acquisition Company (SPAC) Explained: Examples and RisksFebruary 27, 2025 | investopedia.comArchimedes Tech SPAC Partners II Co. Announces Pricing of $200 Million Initial Public OfferingFebruary 11, 2025 | markets.businessinsider.comAngel Studios to Become a Publicly Traded Company via Business Combination with Southport Acquisition CorporationSeptember 12, 2024 | markets.businessinsider.comSemnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln dealSeptember 3, 2024 | reuters.comSemnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 billion dealSeptember 3, 2024 | msn.comSee More Headlines ASCB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of A SPAC II Acquisition own? Based on aggregate information from My MarketBeat watchlists, some other companies that A SPAC II Acquisition investors own include Andretti Acquisition Corp. II (POLEU), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR), Aimfinity Investment Corp. I (AIMAU) and Aimei Health Technology (AFJK). Company Calendar Today3/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry N/A Sub-IndustryTrading Current SymbolNASDAQ:ASCB CIK1876716 WebN/A Phone65-6818-5796FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,296,000Free Float5,851,000Market Cap$81.64 million OptionableNot Optionable Beta-0.02 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:ASCB) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump Shock to change everything Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...Centurion Publishing | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredMagnificent 7 wipeout: What's next?A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding A SPAC II Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share A SPAC II Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
